| Ytd | 6.05% | |
| 1y | -4.84% |
| Open | 94.04 | Prev Close | 94.25 | Low | 93.72 | High | 96.17 | Mkt Cap | 18.19B |
| Vol | 3.95M | Avg Vol | 2.22M | EPS | 4.12 | P/E | 23.15 | Forward P/E | 10.52 |
| Beta | 0.47 | Short Ratio | 4.06 | Inst. Own | 111.41% | Dividend | 0.96 | Div Yield | 1.02 |
| Ex Div Date | 09-30 | Earning | 11-05 | 50-d Avg | 96.09 | 200-d Avg | 91.44 | 1yr Est | 107.57 |
ZBH News
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Zimmer Biomet (NYSE: ZBH - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both
On September 08, 2026, Zimmer Biomet Holdings Inc (ZBH) shares fell 3.9% to a current price of $94.2
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CM
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Jupiter Topco LLC purchased a new stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) in the undefined
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transfor
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a glob
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, tho
Zimmer Biomet (NYSE: ZBH) reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a rep
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Zimmer Biomet NYSE: ZBH reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a repor
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript
ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-ma
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed i
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus
Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant cu
Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the Med
Harris Associates' 13F portfolio rose to $75.42B in Q2 2026, with 30 core positions exceeding 1.25%
Zum Schluss am 18.09.2026 lag die Zimmer-Biomet-Aktie an der New York Stock Exchange bei 95,36 USD u
Zimmer Biomet stock thus remains below its 52-week peak at USD 106.88, but clearly above the 52-week